Stock A304360 S.BIOMEDICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company S.Biomedics CO., LTD.

Equities

A304360

KR7304360001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 22/05/2024 BST 		5-day change 1st Jan Change
38,850 KRW +29.93% Intraday chart for S.Biomedics CO., LTD. +17.02% +237.83%
2023 S.Biomedics CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2023 S.Biomedics CO., LTD. has completed an IPO in the amount of KRW 13.5 billion. CI

Business Summary

S Biomedics Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of biopharmaceuticals. The Company operates business through two segments. The Medical Devices segment engages in the manufacture and sale of medical devices and cosmetics. The Stem Cell Therapeutics segment is primarily engaged in the manufacture and sale of stem cell therapies. Additionally, this segment is engaged in stem cell research and development (R&D).

Sales per Business

KRW in Million2022Weight2023Weight Delta
Medical Equipment
99.4 %
12,034 99.3 % 13,029 99.4 % +8.27%
Stem Cell Therapy
2.2 %
361 3.0 % 291 2.2 % -19.46%
Consolidated Adjustment
-1.6 %
-283 -2.3 % -212 -1.6 % -25.06%

Sales per region

KRW in Million2022Weight2023Weight Delta
Foreign
85.6 %
10,386 85.7 % 11,216 85.6 % +7.99%
South Korea
14.4 %
1,727 14.3 % 1,892 14.4 % +9.59%

Managers

Managers TitleAgeSince
Sae-Il Kang CEO
 Chief Executive Officer 44 28/03/18
Dong-Wook Kim CEO
 Chief Executive Officer 63 30/03/19
Myung-Soo Cho CTO
 Chief Tech/Sci/R&D Officer 55 28/03/19
Won-Geun Kim AUD
 Comptroller/Controller/Auditor 71 -

Members of the board

Members of the board TitleAgeSince
Sae-Il Kang CEO
 Chief Executive Officer 44 28/03/18
Dong-Wook Kim CEO
 Chief Executive Officer 63 30/03/19
Myung-Soo Cho CTO
 Chief Tech/Sci/R&D Officer 55 28/03/19
Sang-Heon Kim BRD
 Director/Board Member 57 29/03/18
Jung-Soon Jang BRD
 Director/Board Member 67 28/03/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,427,076 8,021,980 ( 70.20 %) 0 70.20 %

Shareholders

NameEquities%Valuation
BINEX CO., LTD.
8.067 %
919,552 8.067 % 23 M ₩
Mirae Equity Partners Co., Ltd.
5.847 %
666,500 5.847 % 16 M ₩
NHN CORPORATION
4.939 %
563,000 4.939 % 14 M ₩
Meritz Financial Securities Co., Ltd.
4.694 %
535,068 4.694 % 13 M ₩
Dong-Wook Kim
3.448 %
393,000 3.448 % 10 M ₩
DONGKOOK PHARMACEUTICAL CO., LTD.
0.9747 %
111,112 0.9747 % 3 M ₩
Jong-wan Kim
0.1909 %
21,764 0.1909 % 536 974 ₩

Company contact information

S.Biomedics Co., Ltd.

4F, Wooil Venture Town Building 28, Seongsui-ro 26-gil

04797, Seoul

+

http://www.sbiomedics.com
address S.Biomedics CO., LTD.(A304360)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
S.BIOMEDICS CO., LTD. Stock S.Biomedics CO., LTD.
+237.83% 250M
CSL LIMITED Stock CSL Limited
-1.88% 89.22B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 40.49B
BIOGEN INC. Stock Biogen Inc.
-15.73% 32.79B
UCB Stock UCB
+64.13% 26.23B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-21.28% 14.52B
INCYTE CORPORATION Stock Incyte Corporation
-8.50% 13.09B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-44.07% 11.6B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-13.06% 11.5B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.94% 8.82B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A304360 Stock
  4. Company S.Biomedics CO., LTD.